CME Webinar: Asthma Clinical Guideline Updates

Feb. 2025Education/Webinars

CME Webinar: Asthma Clinical Guideline Updates

Please join us for a live, CME-accredited webinar on Wednesday, April 30, that will provide an overview of asthma clinical guideline updates. During this presentation, our speakers will discuss:

  • The goals of therapy for asthma.
  • The definitions, descriptions, and clinical usefulness of asthma severity.
  • The clinical benefits of single maintenance and reliever (SMART) therapy for steps 1 and 2 of asthma management.

Speakers:

  • Nicholas DeGregorio, MD, MMM, FACP, AVP of Medicaid Services, UPMC Health Plan
  • Lindsay Joseph, PharmD, Clinical Pharmacy Coordinator, UPMC Health Plan
  • Rebecca Nagle, MS, BSN, RN, CPHQ, Director of Medicaid and CHIP Quality Programs, UPMC Health Plan

Register Now

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The maximum number of hours awarded for this Continuing Pharmacy Education is 1.0 contact hour. The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

 Provider is responsible for verifying CME eligibility.


Recent Announcements

Watch for a chance to rate your experience with UPMC Health Plan

Watch for a chance to rate your experience with UPMC Health Plan. You may be randomly selected to participate in a 2026 Press Ganey provider satisfaction survey that will begin this month.
Aug. 2026Important Notices

Voluntary nationwide recall: Cetirizine (Unique – July)

Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is recalling four lots (GY825029, GY825030, GY825031, GY825032) of Cetirizine Hydrochloride Tablets USP 5 mg. Cetirizine is used for the relief of allergy symptoms, including itchy, red, watery eyes and itchy skin.
Jul. 2026Pharmacy Updates

August 2026 UPMC for You and UPMC Community HealthChoices Formulary Updates

Effective Aug. 15, 2026, UPMC for You and UPMC Community HealthChoices are updating their formularies.
Jul. 2026Pharmacy Updates